Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Intravenous Gammaglobulin for Sickle Cell Pain Crises

This study is currently recruiting participants. (see Contacts and Locations)
Verified January 2016 by Albert Einstein College of Medicine of Yeshiva University
Sponsor:
Information provided by (Responsible Party):
Deepa Manwani, Albert Einstein College of Medicine of Yeshiva University
ClinicalTrials.gov Identifier:
NCT01757418
First received: November 8, 2012
Last updated: January 26, 2016
Last verified: January 2016